Korea's drug expenditures on rise

Published: 2002-05-21 06:58:00

Updated: 2002-05-21 06:58:00

The Health Insurance Review Agency (HIRA) says Korea's drug expenditures including treatment outlays amounted to some 1.29 trillion won in the first quarter of this year, rising 20 percent from 1.07 trillion won marked in the same period a year earlier. As a result of dividing the total drug char...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK